Ezgi Körlü Dalgiç

Ezgi Körlü Dalgiç

Auto-generated profile, based on publicly available information

Ezgi Körlü Dalgiç

Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2022 in Acta Medica
Verified
Journal Article
Open access
PDF file
ABAyse Batirel
Ayse Batirel
EKEzgi Korlu
Ezgi Korlu
NENurullah Eser
Nurullah Eser
MTMehmet Engin Tezcan
Mehmet Engin Tezcan
Objectives: Inflammation is the main cause of systemic damage in SARS-COV2 infections. Steroid treatment has been shown to reduce mortality in COVID-19. However, there is no index to monitor treatment responses to steroids. Here, we evaluated the validity of serial C-reactive-protein (CRP) follow-up for predicting the outcome in the patients receiving steroid therapy. Material and methods: In our retrospective cohort study, four hundred twenty-five patients were included. All patients received dexamethasone 6 mg/day or equivalent dose of steroid as much as needed with the onset of hypoxia (SaO2 ≤ 93%). We divided patients into two groups according to outcome (deceased/discharged). We then compared demographic, clinical and laboratory features between the groups. Lastly, we evaluated the thresholds of CRP decline associated with COVID-19 associated mortality at 3th, 5th days and at the end of treatment. Results: COVID 19 associated mortality rate of the cohort was 6.1% (26/425). In multivariate analysis, in which survival was evaluated, parameters related to death due to COVID-19 in the steroid group were high NEWS-2 score (0.82, CI 95 % 0.68-0.97, p=0.02), increased Charlson comorbidity index (0.68,CI 95% 0.51-0.90,p= 0.007) and absolute CRP level at the end of treatment (0.97,CI 95%, p<0.001). In addition, cut-off levels of CRP reduction related to COVID-19-associated mortality during steroid therapy were found as follows: less than 33% (sensitivity 75%, specificity 64.1%) on day 3, less than 43.5% (sensitivity 81.8%, specificity 70.8%) on day 5 and less than 55% at the end of the treatment (sensitivity 80.7%, specificity 71.8%). Conclusions: Serial CRP measurement from the third day of steroid therapy can be used to predict mortality in COVID-19 patients receiving steroids.

13 October 2026 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
SDSafiye Koçulu Demir
Safiye Koçulu Demir
KKKübra Kumluca
Kübra Kumluca
EDEzgi Körlü Dalgiç
Ezgi Körlü Dalgiç
HOHakan Odabaşi
Hakan Odabaşi
AÇAyşe ŞABABLI ÇETİN
Ayşe ŞABABLI ÇETİN
DEDerya Öztürk Engi̇n
Derya Öztürk Engi̇n